MSB 1.49% $1.02 mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-385

  1. 1,159 Posts.
    lightbulb Created with Sketch. 127
    Yeah nah yeh on the koolaid in a big way hey old sport? old bean? old lad?

    "A new study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average cost was $1.3 billion, which was much lower compared to previous studies, which have placed the average cost of drug development as $2.8 billion."

    https://www.lshtm.ac.uk/newsevents/news/2020/average-cost-developing-new-drug-could-be-15-billion-less-pharmaceutical
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.02
Change
0.015(1.49%)
Mkt cap ! $1.164B
Open High Low Value Volume
$1.00 $1.04 94.0¢ $11.76M 11.90M

Buyers (Bids)

No. Vol. Price($)
6 206912 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 37637 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.